news sources

econ charts


sitemap home
GMO & BioTech

gmo page 2  Bioinformatics
     Environmental Genome Project      top
GMO crops   top
  • CNN  Human Genome Project, search cnn health
  • WMR's  February 13-15, 2009 -- Monsanto and Bill Gates -- are they playing a bio-war game in China?   ...   WMR's intelligence sources in China are raising concerns over a program in China that is seeing the introduction of Monsanto-produced genetically-modified strains of wheat in China to combat a deadly stem rust fungus known as Uganda99 or "Ug99." The spread of the fungus from Africa to the Arabian peninsula, Iran, India, and now China, comes at a time when world food prices are increasing due to droughts, water shortages and the removal of arable land for the production of bio-ethanol plants. The introduction of the Monsanto genetically modified organism (GMO) wheat seeds in China is reportedly being carried out with grants from the Bill Gates Foundation and the Rockefeller Foundation.   ...   Some in China worry that Ug99 may be part of a U.S. bio-war program to make countries like China subservient to U.S. food exports during a time when the world is facing shortages in its grain stocks.     ...    The stem rust fungus was in the bio-war stockpiles of the United States and the Soviet union during the Cold War. Ug 99 spread from Uganda in 1999 to Kenya in 2001, Ethiopia in 2003, and in 2007 across the Red Sea into Yemen when cyclone Gonu's winds spread the stem rust spores from Africa into Asia. The spores have now been detected in Iran and the Punjab region of Pakistan.    ...   There is some concern that Monsanto, as well as the Switzerland-based firm Syngenta, are taking advantage of the stem rust plague to introduce GMO seeds to countries like China and India, which have been resistant in the past to such offerings.    ...    The involvement of the U.S. Department of Agriculture's Animal and Plant Health Inspection Service and the connections between its secretive Plum Island laboratory off Long Island and the U.S. Army's bio-war center at Fort Detrick, Maryland, has Chinese official highly concerned about the wheat GMOs from Monsanto and Ug99.    ...   
GMO Labeling    top
Human Genome Project    top
Insects, GMO    top
Pharmacogenetics    top


Baycol Watchdog
List of Genome Databases
Nucleotide Sequence Data Bases:
GenBank - Nucleotide Sequence DB (NCBI, USA)
(European Bioinformatics Institute, UK)
- DNA Data Bank of Japan (National Institute of Genetics, Japan)
GDB - Genome Data Base at Johns Hopkins University (USA).
OMIM - Online Mendelian Inheritance of Man
- This catalog of human genes and genetic diseases authored and edited by Victor A. McKusick contains textual and reference information provided by NCBI server (USA).
A Gene Map of the Human Genome
is created by an international consortium to map gene-based sequence tagged site markers on a set of a two radiation hybrid panels and a YAC library.
The Human Transcript Map

Electronic version of the Science wall chart summarizing over 16,000 human genes that have been mapped relative to a framework map that contains about 1000 polymorphic genetic markers.
Human Genome Sequence Data
at HGC (Berkeley Lab., USA)
(GENETHON Genome Center, France)
in INFOBIOGEN (France)
- ImMunoGeneTics Database (France)
- Human Gene Encyclopedia at EIMB - Engelhardt Institute of Molecular Biology (Moscow, Russia).
TIGR Human Gene Index
integrates research results from international human EST and gene research projects, and represents a non-redundant view of human genes. The Institute of Genomic Research located in Washington DC provides details of its genome sequencing projects and genetics resources.
Human Gene Mutation Database
- Information on known gene lesions responsible for human inherited diseases, searchable by disease or gene name. University of Wales - College of Medicine (Cardiff, UK)
GeneCards Project
Bioinformatics Unit, Genome Center and Weizmann Institute of Science (Israel)
KEGG - Kyoto Encyclopedia of Genes and Genomes
The Kanehisa laboratory (in the Institute for Chemical Research, Kyoto University) and the Human Genome Center (in the Institute of Medical Science, University of Tokyo, Japan)
LDB - The Location Database
is a database for constructing fully integrated genetic and physical maps. The ldb program generates an integrated map (known as the summary map) from partial maps of physical, genetic, regional, mouse homology and cytogenetic data. (Genetic Epidemiology Group of University of Southampton, UK)
STS table and physical maps (5q)
from LBNL - Lawrence Berkeley National Laboratory Genome Center (USA)
IMGT - Immunogenetics Database
from EBI - European Bioinformatics Institute (UK)
Transcription Factor Database
at ICIG (Novosibirsk, Russia) and at GBF-Braunsweig (Germany)
Transcription Region Database
at ICIG (Novosibirsk, Russia)
Transcriptional Regulation of Oncogenes
at ICIG (Novosibirsk, Russia)
RHDB - Radiation Hybrid Database
from EBI - European Bioinformatics Institute (UK)
Restriction Enzyme Database (REBASE)

for nuclear genes
Estimated sizes for human chromosomes
A database of human repeated DNA
at Virtual Genome Center
Protein Databases and Servers
-Protein Information Resources (UK)
- Protein Information Resource (USA)
- Composite Protein Sequence Database (UK)
PDB - Protein Data Bank
(USA) - is an archive of experimentally determined three-dimensional structures of biologically macromolecules.
Kabat Database of Proteins of Immunological Interest
Protein Research Foundation - PRF
(Israel) QUEST Protein Database Center (USA)
Structural Classification of Proteins (SCoP)
ProDom Protein Domain Database

PROLYSIS - protease and protease inhibitors
(Univ. of Tours, France)
is a curated protein sequence database which strives to provide a high level of annotations (such as the description of the function of a protein, its domains structure, post-translational modifications, variants, etc), a minimal level of redundancy and high level of integration with other databases (ExPASy, Switzerland).
- Dictionary of protein sites and patterns (ExPASy, Switzerland)
- Two-dimensional polyacrylamide gel electrophoresis database (ExPASy, Switzerland)
PUMA Database
: Phylogeny, Metabolism, Alignments (Argonne National Laboratory, USA)
- 3D images of proteins and other biological macromolecules (ExPASy, Switzerland)
SWISS-MODEL Repository
- A database of automatically generated protein models (ExPASy, Switzerland)
- Enzyme nomenclature database (ExPASy, Switzerland)
Other (non-Human) Genome Databases and Genome Project Servers
Agricultural Genome (National Agricultural Library)
Arabidopsis Genome Database (AAtDB)

Arabidopsis thaliana Database
Big Blue and MutaMouse Web Site
C. elegans Genome Database (ACeDB)

Integrated Genome Database (IGD)

Maize Genome Database (MaizeDB)

Mouse and Rat Research Home Page
from Eric Mercer
Mouse Genome Informatics
from Jackson Lab (USA)
Mycobacterium Genome Database (MycDB)

Portable Dictionary of the Mouse Genome
>Reference Library DataBase (RLDB2)
Saccharomyces Genomic Information Resource

TBASE - Transgenic and Targeted knockout mice database
(at John Hopkins Univ., USA)
Transgenic and Targeted Mutant Animal Database
(at Oak Ridge)
Uncategorized links
Defense Technical Information Center - Reports on DoD laboratory activites
All Russian Collection of Microorganisms
(Puschino, Russia)
Paul N. Hengen's Home Page
- Editor of biosci.methds-reagnts
Vector Database
from Stephen Miseners
Return to the TOP of this Page
Last modified 26 March 2001 by Bioinformatics Center :

Genetically modified ‘frankenfish’ to appear in US stores
RT Genetically modified ‘frankenfish’ to appear in US stores Get short URL  email story to a friend print version Published: 22 December, 2012, 00:44 TAGS: AnimalsSciTechUSAAgriculture,Science Reuters/Ki Price Regulators with the FDA have released a preliminary report that suggests they will soon give the go-ahead to a team of scientists who’ve created a sci-fi “frankenfish.” On Friday, the US Food and Drug Administration released an environmental assessment report regarding a salmon-hybrid developed in the laboratories of AquaBounty. The FDA must wait two months before they make final their decision regarding the fate of the frankenfish, but through their study they have determined that the genetically engineered animal, the “AquAdvantage,” is safe enough to be sold. The fish, a hybrid of the Pacific Chinook salmon and a ray-finned creature called the eelpout, is engineered to grow twice as normal as traditional salmon. Once the frankenfish is approved for good, AquaBounty will be able to offer meatier fish able to feed more people. “In all other respects,” the company says the AquAdvantage fish is “identical to other Atlantic salmon.” The AquAdvantage "will not have any significant impacts on the quality of the human environment of the United States,” the FDA wrote, noting additionally that the fish is unlikely to harm populations of natural salmon. The FDA has 60 days to hear remarks from the public before it makes its final decision. At this point, though, experts weighing in with the Associated Press say the report suggests an approval is all but certain. From there, AquaBounty is likely to release what will be the first genetically engineered animal ever determined safe for human consumption. With no other such animal ever approved in the past, though, concerns have been plentiful over what consequences the creature could spawn. Bill Freese, a science policy analyst with the Center for Food Safety, told Women’s Health Magazine recently that while the FDA obviously has regulations the fish will have to pass, that process is “totally unlike” how the FDA goes about approving drugs. According to Freese, “a very lax regulatory system” could lead to dire results. “This is a radical new technology. We need very good, careful, close regulation, and we just don't have that. We can't be assured of the safety of any of these genetically engineered organisms,” he said. Developing the frankenfish has so far cost AquaBounty nearly two decades of research and tens of millions of dollars. Only weeks ago, though, the very fate of the fish was put at risk. While awaiting news from the FDA in early December, AquaBounty CEO Ron Stotish told the Associated Press that length delays had nearly drained the company from all their money. "It's threatening our very survival," Stotish told the AP. "We only have enough money to survive until January 2013, so we have to raise more. But the unexplained delay has made raising money very difficult." In 2010, the FDA concluded that the AquaAdvantage fish was just as safe as traditional salmon to eat. Only now, however, has it been finally able to release its environmental assessment report, one of the final steps before AquaBounty can be given the green light.

free hit counter javascript

Baycol Watchdog